The release of a recent EMA reflection paper, aligning with FDA and WHO positions, has resulted in a renewed focus on the central role of pharmacokinetic (PK) data, the primary status of analytical ...

New Cell-Based Assays Support Drug Discovery Across the Amylin Receptor Family STATE COLLEGE, PA, UNITED STATES, ...

Cellular immunogenicity and immunotoxicity assays help scientists design, validate, and translate therapeutic research into treatments that weaponize the immune response against cancer.

Single-cell analysis is a ubiquitous laboratory technique that allows researchers to probe the myriad biomolecular states of cells. Single-cell assays can reveal gene and protein expression patterns, ...

Cell viability constitutes a fundamental measure in biomedical research, serving as an essential indicator of cellular health, metabolic activity and the efficacy of pharmacological treatments. Among ...

Thepatent relates to potency assay methods for assessing human mesenchymal stem cells (MSCs) derived from bone marrow, adipose tissue, peripheral ...

Cell health assessment is the foundation in cancer drug discovery. Potential cancer drug candidates need to show anti-cancer activity such as inhibition of proliferation and induction of apoptosis to ...

Potency assays are central to proving a therapy activity and safety, yet for advanced therapies like cell and gene therapies ...

Validated next-generation sequencing soon will become necessary in ensuring the safety and efficacy of cell and gene therapies while helping scientists to streamline quality-control processes with a ...

Cell-based assays are used to study genes, proteins, and whole cellular functions, as well as the mechanisms that control them, by measuring specific cellular parameters. They have become an important ...

This article is based on a poster originally authored by Blaise Louis, Serena Belluschi, Daniel Weekes, Tom Mitchell, Holly Herbert, Tarun Vemulkar and Jeroen Verheyen, which was presented at ELRIG ...